tetano
Editor, Senior Moderator
Int J Cardiol Heart Vasc
. 2021 Mar 24;100770.
doi: 10.1016/j.ijcha.2021.100770. Online ahead of print.
Subclinical Left Ventricular Dysfunction in COVID-19
Harpreet S Bhatia[SUP] 1 [/SUP], Quan M Bui[SUP] 1 [/SUP], Kevin King[SUP] 1 [/SUP], Anthony DeMaria[SUP] 1 [/SUP], Lori B Daniels[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Coronavirus Disease-2019 (COVID-19) is associated with cardiovascular injury, but left ventricular (LV) function is largely preserved. We aimed to evaluate for subclinical LV dysfunction in patients with COVID-19 through myocardial strain analysis.
Methods: We performed a single-center retrospective cohort study of all patients hospitalized with COVID-19 who underwent echocardiography. Traditional echocardiographic and global longitudinal strain (GLS) values were compared with prior and subsequent echocardiograms.
Results: Among 96 patients hospitalized with COVID-19 with complete echocardiograms, 67 (70%) had adequate image quality for strain analysis. The cohort was predominantly male (63%) and 18% had prevalent cardiovascular disease (CVD). Echocardiograms were largely normal with median [IQR] LV ejection fraction (EF) 62% [56%, 68%]. However, median GLS was abnormal in 91% (-13.5% [-15.0%, -10.8%]). When stratified by CVD, both groups had abnormal GLS, but presence of CVD was associated with worse median GLS (-11.6% [-13.4%, -7.2%] vs -13.9% [-15.0%, -11.3%], p=0.03). There was no difference in EF or GLS when stratified by symptoms or need for intensive care. Compared to pre-COVID-19 echocardiograms, EF was unchanged, but median GLS was significantly worse (-15% [-16%, -14%] vs -12% [-14%, -10%], p=0.003). Serial echocardiograms showed no significant changes in GLS or EF overall, however patients who died had stable or worsening GLS, while those who survived to discharge home showed improved GLS.
Conclusions: Patients with COVID-19 had evidence of subclinical cardiac dysfunction manifested by reduced GLS despite preserved EF. These findings were observed regardless of history of CVD, presence of COVID-19 symptoms, or severity of illness.
Funding sources: Partially supported by the National Institutes of Health, Grant 5T32HL079891, as part of the UCSD Integrated Cardiovascular Epidemiology Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Disclosures: There are no relationships with industry relevant to this manuscript. The authors report no relationships that could be construed as a conflict of interest.
Keywords: COVID-19; Coronavirus; Echocardiography; Myocardial strain.
. 2021 Mar 24;100770.
doi: 10.1016/j.ijcha.2021.100770. Online ahead of print.
Subclinical Left Ventricular Dysfunction in COVID-19
Harpreet S Bhatia[SUP] 1 [/SUP], Quan M Bui[SUP] 1 [/SUP], Kevin King[SUP] 1 [/SUP], Anthony DeMaria[SUP] 1 [/SUP], Lori B Daniels[SUP] 1 [/SUP]
Affiliations
- PMID: 33778152
- PMCID: PMC7988446
- DOI: 10.1016/j.ijcha.2021.100770
Abstract
Background: Coronavirus Disease-2019 (COVID-19) is associated with cardiovascular injury, but left ventricular (LV) function is largely preserved. We aimed to evaluate for subclinical LV dysfunction in patients with COVID-19 through myocardial strain analysis.
Methods: We performed a single-center retrospective cohort study of all patients hospitalized with COVID-19 who underwent echocardiography. Traditional echocardiographic and global longitudinal strain (GLS) values were compared with prior and subsequent echocardiograms.
Results: Among 96 patients hospitalized with COVID-19 with complete echocardiograms, 67 (70%) had adequate image quality for strain analysis. The cohort was predominantly male (63%) and 18% had prevalent cardiovascular disease (CVD). Echocardiograms were largely normal with median [IQR] LV ejection fraction (EF) 62% [56%, 68%]. However, median GLS was abnormal in 91% (-13.5% [-15.0%, -10.8%]). When stratified by CVD, both groups had abnormal GLS, but presence of CVD was associated with worse median GLS (-11.6% [-13.4%, -7.2%] vs -13.9% [-15.0%, -11.3%], p=0.03). There was no difference in EF or GLS when stratified by symptoms or need for intensive care. Compared to pre-COVID-19 echocardiograms, EF was unchanged, but median GLS was significantly worse (-15% [-16%, -14%] vs -12% [-14%, -10%], p=0.003). Serial echocardiograms showed no significant changes in GLS or EF overall, however patients who died had stable or worsening GLS, while those who survived to discharge home showed improved GLS.
Conclusions: Patients with COVID-19 had evidence of subclinical cardiac dysfunction manifested by reduced GLS despite preserved EF. These findings were observed regardless of history of CVD, presence of COVID-19 symptoms, or severity of illness.
Funding sources: Partially supported by the National Institutes of Health, Grant 5T32HL079891, as part of the UCSD Integrated Cardiovascular Epidemiology Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Disclosures: There are no relationships with industry relevant to this manuscript. The authors report no relationships that could be construed as a conflict of interest.
Keywords: COVID-19; Coronavirus; Echocardiography; Myocardial strain.